SI2160202T1 - Pozitrone emitirajoči sestavki, ki vsebujejo anorganske delce, in njihova uporaba v medicini, še zlasti za diagnostične postopke - Google Patents

Pozitrone emitirajoči sestavki, ki vsebujejo anorganske delce, in njihova uporaba v medicini, še zlasti za diagnostične postopke

Info

Publication number
SI2160202T1
SI2160202T1 SI200830970T SI200830970T SI2160202T1 SI 2160202 T1 SI2160202 T1 SI 2160202T1 SI 200830970 T SI200830970 T SI 200830970T SI 200830970 T SI200830970 T SI 200830970T SI 2160202 T1 SI2160202 T1 SI 2160202T1
Authority
SI
Slovenia
Prior art keywords
medicine
inorganic particles
containing inorganic
diagnostic processes
emitting positrons
Prior art date
Application number
SI200830970T
Other languages
English (en)
Inventor
Kristian Schilling
Original Assignee
Nanopet Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanopet Pharma Gmbh filed Critical Nanopet Pharma Gmbh
Publication of SI2160202T1 publication Critical patent/SI2160202T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SI200830970T 2007-06-22 2008-06-20 Pozitrone emitirajoči sestavki, ki vsebujejo anorganske delce, in njihova uporaba v medicini, še zlasti za diagnostične postopke SI2160202T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07110908A EP2005973A1 (de) 2007-06-22 2007-06-22 Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren
EP08761289A EP2160202B1 (de) 2007-06-22 2008-06-20 Positronen emittierende anorganische partikel enthaltende zusammensetzungen und deren verwendung in der medizin, insbesondere für diagnostische verfahren
PCT/EP2008/057917 WO2009000785A2 (de) 2007-06-22 2008-06-20 Positronen emittierende anorganische partikel enthaltende zusammensetzungen und deren verwendung in der medizin, insbesondere für diagnostische verfahren

Publications (1)

Publication Number Publication Date
SI2160202T1 true SI2160202T1 (sl) 2013-09-30

Family

ID=38624000

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830970T SI2160202T1 (sl) 2007-06-22 2008-06-20 Pozitrone emitirajoči sestavki, ki vsebujejo anorganske delce, in njihova uporaba v medicini, še zlasti za diagnostične postopke

Country Status (13)

Country Link
US (1) US8894968B2 (sl)
EP (2) EP2005973A1 (sl)
JP (1) JP5635400B2 (sl)
CN (1) CN101801421B (sl)
CA (1) CA2691580C (sl)
DK (1) DK2160202T3 (sl)
ES (1) ES2421441T3 (sl)
HR (1) HRP20130496T1 (sl)
IL (1) IL202870A (sl)
PT (1) PT2160202E (sl)
RU (1) RU2461392C2 (sl)
SI (1) SI2160202T1 (sl)
WO (1) WO2009000785A2 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681933A1 (en) * 2006-04-03 2007-11-08 Dorothee Goldman Methods and kit for endometriosis screening
EP2005973A1 (de) 2007-06-22 2008-12-24 nanoPET Pharma GmbH Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren
KR100991716B1 (ko) * 2009-10-22 2010-11-04 경북대학교 산학협력단 광학영상 조영제, 그 용도 및 장치
CA2808651C (en) 2010-08-20 2018-08-14 Oratel Diagnostics, Llc Estrous cycle monitoring by color response
US8562874B2 (en) 2011-02-28 2013-10-22 Ada Foundation Method for preparation of well-dispersed, discrete nanoparticles by spray drying techniques
WO2013009813A1 (en) * 2011-07-11 2013-01-17 Oratel Diagnostics, Llc Methods and kit for endometriosis diagnosis
WO2018127912A1 (en) * 2017-01-03 2018-07-12 Yeda Research And Development Co. Ltd. Mri tracers comprising inorganic nanofluorides
JP6998008B2 (ja) * 2017-08-31 2022-01-18 国立研究開発法人産業技術総合研究所 分散性リン酸カルシウムナノ粒子、分散性リン酸カルシウムナノ粒子の製造方法、医薬品及び分散性リン酸カルシウムナノ粒子作製キット医薬品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
GB9020075D0 (en) * 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US7731648B2 (en) * 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
WO2006064453A2 (en) * 2004-12-17 2006-06-22 Koninklijke Philips Electronics N.V. Targeting agents for molecular imaging
CN101080240A (zh) * 2004-12-17 2007-11-28 皇家飞利浦电子股份有限公司 用于分子成象和治疗的靶向造影剂或靶向治疗剂
US20070264199A1 (en) * 2005-09-26 2007-11-15 Labhasetwar Vinod D Magnetic nanoparticle composition and methods for using the same
EP2005973A1 (de) 2007-06-22 2008-12-24 nanoPET Pharma GmbH Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren

Also Published As

Publication number Publication date
HRP20130496T1 (hr) 2013-08-31
EP2160202B1 (de) 2013-03-06
WO2009000785A2 (de) 2008-12-31
RU2010101926A (ru) 2011-07-27
IL202870A (en) 2015-03-31
DK2160202T3 (da) 2013-06-10
CA2691580C (en) 2015-11-24
ES2421441T3 (es) 2013-09-02
WO2009000785A3 (de) 2009-05-22
EP2005973A1 (de) 2008-12-24
CN101801421A (zh) 2010-08-11
JP5635400B2 (ja) 2014-12-03
US8894968B2 (en) 2014-11-25
CA2691580A1 (en) 2008-12-31
PT2160202E (pt) 2013-07-10
EP2160202A2 (de) 2010-03-10
JP2010530967A (ja) 2010-09-16
RU2461392C2 (ru) 2012-09-20
US20100272637A1 (en) 2010-10-28
CN101801421B (zh) 2016-01-20

Similar Documents

Publication Publication Date Title
HRP20130496T1 (hr) Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
PL2142220T3 (pl) Środki hemostatyczne oparte na glince oraz urządzenia do ich dostarczania
IL216254A (en) Compounds, pharmaceutical compositions and their uses
ZA200908584B (en) Benefit agent containing delivery particle
IL206127A0 (en) Azolylmethyloxiranes, use thereof and agents containing the same
IL217541A0 (en) Triazolopyridine compounds, compositions comprising the same and uses thereof
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
ZA201000185B (en) 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2057987A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ENCAPSULATED STATINE NANOPARTICLE
IL199615A (en) Urea factories glucokinase medications containing them and their use
EP2218433A4 (en) MEDICAL CONTAINER AND SET OF MEDICAL CONTAINERS
EP2073825A4 (en) COMPOSITION BASED ON CINNAMOMI AND PORIA AND USES THEREOF
HK1200446A1 (zh) 哌啶化合物、含有該化合物的藥物組合物及其用途
EP2261221A4 (en) EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND PREPARATIONS
IL217500A0 (en) Tetrazole derivatives, their preparartion and pharmaceutical compositions containing them
IL217053A0 (en) Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HUP0700269A2 (en) Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
GB0719248D0 (en) Compounds and methods for pharmaceutical use
PL2448920T3 (pl) Związki benzenosulfonamidowe, sposób ich syntezy i zastosowanie w medycynie
SI2266619T1 (sl) Farmacevtski sestavek na osnovi hepatoprotektorja in prebiotika, njegova izdelava in uporaba
EP2017257A4 (en) 2-AMINOBUTANOL COMPOUND AND ITS USE FOR MEDICAL PURPOSES
HK1141991A1 (en) Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer